#BEGIN_DRUGCARD DB08344

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C24H31ClN2O2

# Chemical_IUPAC_Name:
4-chloro-N-(3-methoxypropyl)-N-[(3S)-1-(2-phenylethyl)piperidin-3-yl]benzamide

# Chemical_Structure:
Not Available

# Creation_Date:
2010-09-15 15:30:57 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
4-chloro-N-(3-methoxypropyl)-N-[(3S)-1-(2-phenylethyl)piperidin-3-yl]benzamide

# HET_ID:
P21

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C24H31ClN2O2/c1-29-18-6-16-27(24(28)21-10-12-22(25)13-11-21)23-9-5-15-26(19-23)17-14-20-7-3-2-4-8-20/h2-4,7-8,10-13,23H,5-6,9,14-19H2,1H3/t23-/m0/s1

# InChI_Key:
InChIKey=OOUGHDJEJNMXSV-QHCPKHFHSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
8350

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
414.968

# Molecular_Weight_Mono:
414.207405953

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
Not Available

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
4.3

# Predicted_LogS:
-4.8

# Predicted_Water_Solubility:
5.89e-03 g/l

# Primary_Accession_No:
DB08344

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
23644580

# PubChem_Substance_ID:
99444815

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
Not Available

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
[H][C@@]1(CCCN(CCC2=CC=CC=C2)C1)N(CCCOC)C(=O)C1=CC=C(Cl)C=C1

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:26:44 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Cytoplasm (By similarity)

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_1_Essentiality:
Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
L42023

# Drug_Target_1_GenBank_ID_Protein:
3212176

# Drug_Target_1_GeneCard_ID:
glmU

# Drug_Target_1_Gene_Name:
glmU

# Drug_Target_1_Gene_Sequence:
>1020 bp
ATGGCAATTAAAATTGGTATCAATGGTTTTGGTCGTATCGGCCGTATCGTATTCCGTGCA
GCACAACACCGTGATGACATTGAAGTTGTAGGTATTAACGACTTAATCGACGTTGAATAC
ATGGCTTATATGTTGAAATATGATTCAACTCACGGTCGTTTCGACGGCACTGTTGAAGTG
AAAGATGGTAACTTAGTGGTTAATGGTAAAACTATCCGTGTAACTGCAGAACGTGATCCA
GCAAACTTAAACTGGGGTGCAATCGGTGTTGATATCGCTGTTGAAGCGACTGGTTTATTC
TTAACTGATGAAACTGCTCGTAAACATATCACTGCAGGCGCAAAAAAAGTTGTATTAACT
GGCCCATCTAAAGATGCAACCCCTATGTTCGTTCGTGGTGTAAACTTCAACGCATACGCA
GGTCAAGATATCGTTTCTAACGCATCTTGTACAACAAACTGTTTAGCTCCTTTAGCACGT
GTTGTTCATGAAACTTTCGGTATCAAAGATGGTTTAATGACCACTGTTCACGCAACGACT
GCAACTCAAAAAACTGTGGATGGTCCATCAGCTAAAGACTGGCGCGGCGGCCGCGGTGCA
TCACAAAACATCATTCCATCTTCAACAGGTGCAGCGAAAGCAGTAGGTAAAGTATTACCT
GCATTAAACGGTAAATTAACTGGTATGGCTTTCCGTGTTCCAACGCCAAACGTATCTGTT
GTTGATTTAACAGTTAATCTTGAAAAACCAGCTTCTTATGATGCAATCAAACAAGCAATC
AAAGATGCAGCGGAAGGTAAAACGTTCAATGGCGAATTAAAAGGCGTATTAGGTTACACT
GAAGATGCTGTTGTTTCTACTGACTTCAACGGTTGTGCTTTAACTTCTGTATTTGATGCA
GACGCTGGTATCGCATTAACTGATTCTTTCGTTAAATTGGTATCTTGGTACGATAACGAA
ACGGGTTACTCAAACAAAGTATTAGACTTAGTAGCTCATATCTACAACTACAAAGGCTAA

# Drug_Target_1_General_Function:
Cell wall/membrane/envelope biogenesis

# Drug_Target_1_General_References:
7542800	Fleischmann RD, Adams MD, White O, Clayton RA, Kirkness EF, Kerlavage AR, Bult CJ, Tomb JF, Dougherty BA, Merrick JM, et al.: Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science. 1995 Jul 28;269(5223):496-512.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
6789

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
49287.0

# Drug_Target_1_Name:
Bifunctional protein glmU

# Drug_Target_1_Number_of_Residues:
456

# Drug_Target_1_PDB_ID:
Not Available

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00132	Hexapep
PF00483	NTP_transferase

# Drug_Target_1_Protein_Sequence:
>Bifunctional protein glmU
MTKKALSAVILAAGKGTRMYSDLPKVLHTIAGKPMVKHVIDTAHQLGSENIHLIYGHGGD
LMRTHLANEQVNWVLQTEQLGTAHAVQQAAPFFKDNENIVVLYGDAPLITKETLEKLIEA
KPENGIALLTVNLDNPTGYGRIIRENGNVVAIVEQKDANAEQLNIKEVNTGVMVSDGASF
KKWLARVGNNNAQGEYYLTDLIALANQDNCQVVAVQATDVMEVEGANNRLQLAALERYFQ
NKQASKLLLEGVMIYDPARFDLRGTLEHGKDVEIDVNVIIEGNVKLGDRVKIGTGCVLKN
VVIGNDVEIKPYSVLEDSIVGEKAAIGPFSRLRPGAELAAETHVGNFVEIKKSTVGKGSK
VNHLTYVGDSEIGSNCNIGAGVITCNYDGANKFKTIIGDDVFVGSDTQLVAPVKVANGAT
IGAGTTITRDVGENELVITRVAQRHIQGWQRPIKKK

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Catalyzes the last two sequential reactions in the de novo biosynthetic pathway for UDP-GlcNAc. Responsible for the acetylation of Glc-N-1-P to give GlcNAc-1-P and for the uridyl transfer from UTP to GlcNAc-1-P which produces UDP-GlcNAc (By similarity)

# Drug_Target_1_SwissProt_ID:
P43889

# Drug_Target_1_SwissProt_Name:
GLMU_HAEIN

# Drug_Target_1_Synonyms:
Glucosamine-1-phosphate N-acetyltransferase
N-acetylglucosamine-1-phosphate uridyltransferase
UDP-N-acetylglucosamine pyrophosphorylase

# Drug_Target_1_Theoretical_pI:
6.59

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB08344
